| Original language | English |
|---|---|
| Pages (from-to) | 449-451 |
| Number of pages | 3 |
| Journal | Circulation Research |
| Volume | 132 |
| Issue number | 4 |
| DOIs | |
| State | Published - Feb 17 2023 |
Bibliographical note
Funding Information:The authors’ research work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL139748 and R35HL155649) and the American Heart Association Strategically Focused Research Networks (SFRN) in Vascular Disease (18SFRN33960163). The content in this editorial is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Funding
The authors’ research work was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health (R01HL139748 and R35HL155649) and the American Heart Association Strategically Focused Research Networks (SFRN) in Vascular Disease (18SFRN33960163). The content in this editorial is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
| Funders | Funder number |
|---|---|
| National Institutes of Health (NIH) | R01HL139748, R35HL155649 |
| National Heart, Lung, and Blood Institute (NHLBI) | |
| American Heart Association | 18SFRN33960163 |
Keywords
- Editorials
- angiotensin II
- extracellular matrix
- macrophages
- matrix metalloproteinases
ASJC Scopus subject areas
- Physiology
- Cardiology and Cardiovascular Medicine